A Geneva hospital is resuming tests of an experimental Ebola vaccine licensed by Merck & Co. after a three-week pause in the trial to assess reports of mild joint pain in volunteers.
via WSJ.com: World News http://ift.tt/1tDkoU7
via WSJ.com: World News http://ift.tt/1tDkoU7
Nessun commento:
Posta un commento